A research team at the Medical University of Vienna led by Maria Sibilia has investigated a new combination therapy against cancer.
Cerebral to pay nearly $3.7M over controlled substance prescribing practices
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS